However, the tumor progression-related functions of CD73 are not self-induced but are ultimately exerted through P1 receptors, especially A2AR and A2BR, which are activated by extracellular ADO, which is produced by CD73 [3]. The gene discussed is ADORA2A; the disease is neoplasm.